Tradewinds Capital Management, LLC
Position in SLS — SELLAS Life Sciences Group, Inc.
CIK 1616026
BELLINGHAM, WA
Position in SLS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$14,760
New position
Shares Held
1,000
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#23
of 34 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tradewinds Capital Management, LLC holds $130,589 across 18 Biotechnology names. SLS ranks #2 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
1,073 | $58,521 | |
| 2 | SLS |
SELLAS Life Sciences Group, Inc.
This page
|
1,000 | $14,760 | |
| 3 | ABCL |
AbCellera Biologics Inc.
|
1,837 | $14,420 | |
| 4 | QURE |
uniQure N.V.
|
200 | $9,212 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
100 | $7,827 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
500 | $4,377 | |
| 7 | ARDX |
Ardelyx, Inc.
|
816 | $4,161 | |
| 8 | VYGR |
Voyager Therapeutics, Inc.
|
1,000 | $3,500 |
All Filings in SLS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,760 | 1,000 | Shares | Sole | 2026-07-24 | |
| No filing history on record for this holder in this stock. | ||||||